REDUCTION OF HEALTH COSTS

MEDICAL MARKETING SUPERHEROES

BLOCKCHAIN TECHNOLOGY

ETHICAL BUSINESS STIMULATES BEST VALUE IN HEALTH ECONOMY

The Virtual World of Digital Clinical Trials

Academic Ventures and Professional Service Companies

MICRONEEDLE ARRAY PATCHES

Systematic Framework for Implementation of RTD-based Control System into Continuous Pharmaceutical Manufacturing Pilot-plant

CUSTOMER CENTRICITY ON SOCIAL MEDIA

IOT AND AI CREATE ‘SMART’ DIGITAL ASSISTANTS

Get instant access to latest e-book

LATEST NEWSRead more...

23

May 2019

Be The Match BioTherapies® Announces Strategic Collaboration with Kiadis Pharma to Accelerate Patient Access to Haploidentical Stem Cell Therapies

Be The Match BioTherapies an organization offering solutions for companies developing and commercializing cell and gene therapies and Kiadis Pharma NV Kiadis Euronext Amsterdam and Brussels KDS a clinical stage biopharmaceutical company today announced a strategic collaboration to support clinical e...

23

May 2019

Halozyme Announces argenx Has Selected Second Target Under ENHANZE Technology Collaboration And License Agreement

Halozyme Therapeutics Inc a biotechnology company developing novel oncology and drugdelivery therapies today announced that argenx has selected a second target under the collaboration and license agreement the companies announced in February

22

May 2019

Gotham Therapeutics and ZoBio Achieve Significant Milestone in Epitranscriptomic Drug Discovery Collaboration

Gotham Therapeutics a biotechnology company developing a novel drug class targeting RNAmodifying proteins and ZoBio the leading contract research organization in integrated fragmentbased drug discovery today announced significant progress made as part of their collaboration to identify therapeutic l...

22

May 2019

Merck to Acquire Peloton Therapeutics, Bolstering Oncology Pipeline

Merck known as MSD outside the United States and Canada and Peloton Therapeutics Inc today announced that the companies have entered into a definitive agreement under which Merck through a subsidiary will acquire privately held Peloton a clinicalstage biopharmaceutical company

21

May 2019

Kazia Enters Clinical Collaboration for Metastatic Brain Cancer with Alliance for Clinical Trials in Oncology

Kazia Therapeutics Limited an Australian oncologyfocused biotechnology company is pleased to announce that it has entered into a collaboration with the Alliance for Clinical Trials in Oncology Foundation Alliance a USbased cancer research network sponsored by the National Cancer Institute

press releasesRead more...

23

May 2019

ProBioGen and Abcuro Signed GlymaxX®-Improved Cell Line Development and GMP Production Agreement

ProBioGen AG a premier service and technology provider for complex therapeutic antibodies and glycoproteins today announced the closing of a services and license agreement with Abcuro Inc Pursuing a new generation of immune modulatory biotherapeutics Abcuro has developed a new first in class antibod...

23

May 2019

Agile Therapeutics Announces FDA Acceptance of the NDA Resubmission of Twirla®

Agile Therapeutics Inc a womens healthcare company today announced that the US Food and Drug Administration FDA has accepted for review the Companys New Drug Application NDA resubmission for Twirla AG an investigational lowdose combined hormonal contraceptive patch

23

May 2019

Kalytera Announces Engagement of Echelon Wealth Partners to Assist with Review of Potential Out-License Opportunities for Commercial Rights to GVHD Products

Kalytera Therapeutics Inc has engaged Echelon Wealth Partners to determine the value on a riskadjusted basis of its cannabidiol CBD therapeutic products for the prevention and treatment of graft versus host disease GVHD and to assist with the review of potential outlicensing opportunities for the co...

22

May 2019

Avalon GloboCare Partners with MIT to Develop Innovative AI-Enhanced Protein Design Technology in Cellular Therapy

Avalon GloboCare Corp a leading global developer of cellbased technologies and therapeutics today announced it has entered into a sponsored research and licensing agreement with Massachusetts Institute of Technology MIT to generate novel therapeutic targets for cellular therapy using artificial inte...

22

May 2019

Santhera Starts Collaboration in Gene Therapy Research for Congenital Muscular Dystrophy with the Biozentrum, University of Basel, Co-Financed by Innosuisse

Santhera Pharmaceuticals announces its collaboration with the Biozentrum of the University of Basel to advance gene therapy research for the treatment of LAMAdeficient congenital muscular dystrophy LAMA MD or MDCA

EventsRead more...

23 - 24

May 2019

Hospital Management and Patient Safety 2019

Meetings International Pte Ltd
Las Vegas

28 - 28

May 2019

10th Annual Clinical Trials Summit 2019

Virtue Insight
Kohinoor Continental Hotel

28 - 30

May 2019

8th Annual Biologics Manufacturing Korea 2019

Imapac
Novotel Ambassador Seoul Gangnam

03 - 04

Jun 2019

Pre-Filled Syringes West Coast 2019

Hyatt Regency Mission Bay Spa and Marina

AirBridgeCargo - Air frieght solutions for your Pharma

$Matcon Efficently handling tablets and powders in IBC\'s$

KNOWLEDGE BANK

Interviews

Merck

Staff Engineer, Manufacturing Science and Technology, South East Asia
Karen Chan is a process engineer at Merck Pte Ltd Chan has six years of experience in the biopharmaceutical industry and two years of experience in research development She provides technical support in areas such as process development troubleshoot...

Articles

Ligand Decorated Theranostic Nanomedicines

The drug absorption in cancer cells from the conventional dosage form is limited due to poor dissolution toxic effect and drug resistance along with debilitating adverse effects such as nausea vomiting temporary loss of physical strength and energy neuropathy and finally organ failure

Research Insights

Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine

Abstract Background Inflammatory breast cancer IBC is a rare aggressive form of breast cancer associated with HER amplification with high risk of metastasis and an estimated median survival of y We performed an openlabel singlearm phase II clinical trial ClinicalTrialsgov NCT to in

Case Studies

Rapid, Comprehensive, And Aff Ordable Mycobacterial Diagnosis With Whole-genome Sequencing: A Prospective Case Study

Abstract Background Slow and cumbersome laboratory diagnostics for Mycobacterium tuberculosis complex MTBC risk delayed treatment and poor patient outcomes Wholegenome sequencing WGS could potentially provide a rapid and comprehensive diagnostic solution In this prospective study we compare realtime

Techno Trends

UW–Madison School of Pharmacy Designs New Compounds to Fight Deadly Mosquito-Transmitted Viruses

UWMadison school of Pharmacy designed a breakthrough in creating new small molecules that penetrate into the brain where the virus resides and interfere with viral replication to stop Equine Encephalitis Viruses EEV

White Papers

Launching Global Clinical Trials—best Practices For Efficient And Cost-effective Translations: A Lionsbridge White Paper

Summary The target market for conducting global clinical trials has changed significantly moving beyond pharmaceutical early adopters to the mainstream marketplace This shift has placed a heightened focus on the language challenges and complexity of running a global clinical trial More and more companies are moving toward

Advisory Board

Stella

Sanjoy Ray

Rustom

Phil

Neil J

Laurence

Kenneth I

Georg C

Frank A

Douglas

Christopher-

Alan S Louie

EDITORIAL SECTION

STRATEGY

ETHICAL BUSINESS STIMULATES BEST VALUE IN HEALTH ECONOMY

Seventy years ago average life expectancy globally was today it is Seventy years ago million people worldwide were infected with smallpox today non...

RESEARCH DEVELOPMENT

Academic Ventures and Professional Service Companies

Over the past few decades life science and pharma have been characterised by a series of radical changes that have been at the origin of an impressive...

CLINICAL TRIALS

Speed, Quality and Cost

In recent years the pharmaceutical industry has seen tremendous changes in the way it is expected to deliver new drugs to market being under increasin...

MANUFACTURING

CLINICAL MANUFACTURING ON TIME AND WITHIN BUDGET

The key to successfully developing and shepherding a drug to the approval stage and beyond lies in careful planning right from the start of developmen...

Information Technology

CUSTOMER CENTRICITY ON SOCIAL MEDIA

Imagine checking into a hotel late in the night but not being able to get the room you had so carefully chosen because the call centre didnt align wit...

EXPERT Talk

How SMEs Can Achieve Regulatory Compliance through a Risk-Based Approach

What is the current consensus on the ICH E R Addendum within SMEs The complexity and size of clinical trials has intensified over recent years alo...

REDUCTION OF HEALTH COSTS

MEDICAL MARKETING SUPERHEROES

BLOCKCHAIN TECHNOLOGY

ETHICAL BUSINESS STIMULATES BEST VALUE IN HEALTH ECONOMY

The Virtual World of Digital Clinical Trials

Academic Ventures and Professional Service Companies

MICRONEEDLE ARRAY PATCHES

Systematic Framework for Implementation of RTD-based Control System into Continuous Pharmaceutical Manufacturing Pilot-plant

CUSTOMER CENTRICITY ON SOCIAL MEDIA

IOT AND AI CREATE ‘SMART’ DIGITAL ASSISTANTS

Get instant access to latest e-book

LATEST NEWSRead more...

23

Be The Match BioTherapies® Announces Strategic Collaboration with Kiadis Pharma to Accelerate Patient Access to Haploidentical Stem Cell Therapies

23

Halozyme Announces argenx Has Selected Second Target Under ENHANZE Technology Collaboration And License Agreement

22

Gotham Therapeutics and ZoBio Achieve Significant Milestone in Epitranscriptomic Drug Discovery Collaboration

22

Merck to Acquire Peloton Therapeutics, Bolstering Oncology Pipeline

21

Kazia Enters Clinical Collaboration for Metastatic Brain Cancer with Alliance for Clinical Trials in Oncology

press releasesRead more...

23

ProBioGen and Abcuro Signed GlymaxX®-Improved Cell Line Development and GMP Production Agreement

23

Agile Therapeutics Announces FDA Acceptance of the NDA Resubmission of Twirla®

23

Kalytera Announces Engagement of Echelon Wealth Partners to Assist with Review of Potential Out-License Opportunities for Commercial Rights to GVHD Products

22

Avalon GloboCare Partners with MIT to Develop Innovative AI-Enhanced Protein Design Technology in Cellular Therapy

22

Santhera Starts Collaboration in Gene Therapy Research for Congenital Muscular Dystrophy with the Biozentrum, University of Basel, Co-Financed by Innosuisse

EventsRead more...

23 - 24

Hospital Management and Patient Safety 2019

28 - 28

10th Annual Clinical Trials Summit 2019

28 - 30

8th Annual Biologics Manufacturing Korea 2019

03 - 04

Pre-Filled Syringes West Coast 2019

Advertisements

TOP ARTICLES

1

Industry 4.0: A Closed Micronisation System

2

Nanomedicines management for advance therapy of NeuroAIDS: State of art

3

Mock-up in The Design Stage - FPS’s particular attention

4

MicroRNA (miRNA) in Nanostructure Lipid Carriers based Tumor Gene Therapy

5

Identification of MicroRNAs and Their Targets in Cancer

KNOWLEDGE BANK

Merck

Ligand Decorated Theranostic Nanomedicines

Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine

Rapid, Comprehensive, And Aff Ordable Mycobacterial Diagnosis With Whole-genome Sequencing: A Prospective Case Study

UW–Madison School of Pharmacy Designs New Compounds to Fight Deadly Mosquito-Transmitted Viruses

Launching Global Clinical Trials—best Practices For Efficient And Cost-effective Translations: A Lionsbridge White Paper

Advisory Board

EDITORIAL SECTION

ETHICAL BUSINESS STIMULATES BEST VALUE IN HEALTH ECONOMY

Academic Ventures and Professional Service Companies

Speed, Quality and Cost

CLINICAL MANUFACTURING ON TIME AND WITHIN BUDGET

CUSTOMER CENTRICITY ON SOCIAL MEDIA

How SMEs Can Achieve Regulatory Compliance through a Risk-Based Approach